Zetagen

Developer of targeted therapies for metastatic and primary breast cancers

placeSyracuse, New York, United States calendar_todayFounded 2017 groups9 employees language zetagen.com

Registered entities

Social engagement

Social engagement: 530 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include New York State, Consolidated Investment Group.

Investor typeCountShare
Private equity133%
Other / undisclosed267%

Recent activity

5 Dec 2025
Event
SABCS Poster Presentation - Poster #PO3-13-01
Coming soon